Minomic have developed a non-invasive test for prostate cancer, called MiCheck. It is more specific than existing tests, therefore, once commercialised, would reduce the rate of false positive results and unnecessary biopsies.
This client worked hard on their investor presentation and after many drafts and hours of effort they realised the content wasn’t meeting their needs. What they wanted was a strong presentation that would land them the investor funding they needed. Not only did they need great graphics but they also needed a strong message that made a complex solution easy to ‘get’. When you are pitching against a 100 other companies on the same day for funding it needs to inspire action. AOK is proud to say they raised $5M in funding.